Pharmaceutical Preparations · DE · CIK 1420720
iBio uses AI to develop precision antibodies for cardiometabolic and obesity diseases
Comparable business profile · signals at a glance
In the 90 days to Mar 26, 2026: 3 insiders bought $98K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Banjak MarcChief Legal Officer | Buy | 12,500 | $1.64 | $21K |
| Mar 26, 2026 | Banjak MarcChief Legal Officer | Buy | 1,434 | $1.76 | $3K |
| Mar 19, 2026 | Duran FelipeChief Financial Officer | Buy | 24,835 | $2.02 | $50K |
| Mar 19, 2026 | Brenner MartinSee Remarks | Buy | 12,336 | $2.02 | $25K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.